Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Extensive research has led to an expansion of the Intellectual Capital…
Drawbacks of conventional parenteral drug delivery systems have paved the way for the development of improved techniques and better drug administration devices. Over the past few years, there has been an evident shift towards the self-administration of drugs / therapies. These self-injection devices facilitate the effective administration of therapeutics for the treatment of emergency and chronic conditions. Drawbacks of conventional parenteral drug delivery systems have paved the way for the...
PR Newswire
02/08/2023
Akari Therapeutics Announces the Appointment of Beth-Anne Lang as Senior Vice…
NEW YORK and LONDON, Aug.02, 2023(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of Beth-Anne Lang, as Senior Vice President, Regulatory Affairs. Ms. Lang has more than 20 years of experience in regulatory strategy, regulatory affairs, and drug development. She will start at Akari in this role on September 1, 2023.“Beth has a long track...
Nasdaq GlobeNewswire
02/08/2023
Grünenthal and Kyowa Kirin International Announce Successful Completion of Deal…
"Grünenthal is a global leader in pain management. With the addition of this strong portfolio, we will be able to help more patients who suffer from various forms of pain," said Gabriel Baertschi, Chief Executive Officer, Grünenthal. "Grünenthal is a global leader in pain management. With the addition of this strong portfolio, we will be able to help more patients who suffer from various forms of pain," saidGabriel Baertschi, Chief Executive Officer, Grünenthal. "The…
PR Newswire
02/08/2023
INTRODUCING THE SIMPLE TRUTH REPORT
Download the Simple Truth Report here. Download the Simple Truth Reporthere. We have cared for skin since 1960, using the purest possible skin-loving ingredients, and nothing else. Simple started when a British chemist created the world's first perfume and colour-free skincare to soothe his children's sensitive skin – it went on to become a household staple. Since then, we have witnessed great change, but the needs of our skin remain the same no matter how much time has passed;...
PR Newswire
02/08/2023
Amarin Reports Second Quarter 2023 Financial Results
-- Company Reported Total Net Revenues of $80 Million in Second Quarter 2023; Total Net Revenues Included Net Product Revenues of $65 Million, $15 Million in License and Royalty Revenues, of Which $11 Million is Non-Cash -- -- Delivered Positive Cash Flow of $9 Million in the Quarter with a Cash Position of $313 Million ---- Comprehensive Cost Reduction Plan Implemented in July with Expected Savings of $40 Million Over 12 Months---- Received Positive Recommendation from Spanish...
Nasdaq GlobeNewswire
02/08/2023
Theriva™ Biologics Announces Key Progress in VIRAGE, an Ongoing, Multinational…
– Initiated dosing at U.S. sites for VIRAGE – – Second doses of intravenous VCN-01administered to patients in Spain and were well tolerated – – VIRAGE remains on track to complete enrollment in the first quarter of 2024 – ROCKVILLE, Md., Aug.02, 2023(GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced key...
Nasdaq GlobeNewswire
02/08/2023
Tending to a growing need for specialized solutions FertiClinic Fertilization…
Recent estimates suggest that one in six UAE couples face difficulties conceiving, and the country's overall fertility rate has significantly declined from 2.7 births per woman in 2000 to 1.5 births per woman in 2020. These figures highlight a growing need for specialized solutions. Additionally, theMiddle East'sinfertility rate is estimated to be around 15 percent, a relatively high regional rate when compared to the 10 percent infertility rate around the rest of the world,...
PR Newswire
02/08/2023
CDR-Life Announces Second Milestone Achievement with Boehringer Ingelheim in…
Companies are partnered to advance a novel therapy with the aim to preserve sight for people living with blinding retinal disease CDR-Life Inc.today announced a milestone payment triggered by the achievement of a development milestone with a partnered antibody fragment-based drug candidate that could significantly slow down the progression of geographic atrophy (GA). Boehringer Ingelheim and CDR-Life entered a collaboration and licensing agreement in May 2020 and announced the selection of...
Nasdaq GlobeNewswire
02/08/2023
Experts advise on how the UK's unpredictable weather could impact one's beauty…
If one's skin is rosacea or eczema prone, or they are unsure which products best suit, intelligent beauty marketplace Sourcerie has designed an expert tool fuelled by customer reviews, to recommend personalised matches for skin types with over 90% accuracy, like having a derm in one's pocket. If one's skin is rosacea or eczema prone, or they are unsure which products best suit, intelligent beauty marketplace Sourcerie has designed an expert tool fuelled by customer reviews, to recommend...
PR Newswire
02/08/2023
Biocomposites appoints two new Directors to strengthen its team for its next…
KEELE, England, Aug. 2, 2023 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has strengthened its leadership team with the addition of two new Directors. Michelle Lewis has become Human Resources Director and Ciara Airey has become Regulatory Affairs Director. Both appointments come in response to the company's strong growth and the need to manage an…
PR Newswire
02/08/2023
3B Scientific acquires Lifecast Body Simulation
Launched in 2017, Lifecast has developed a range of highly accurate and lifelike medical manikins which are transforming the way medical simulation and education are delivered and absorbed. Designed and produced at the renowned Elstree Film Studios inLondonand inSarasota, Florida, every manikin demonstrates a remarkable level of realism and the very highest quality. Todd A. Murray, CEO,3BScientific, commented: "Lifecast Body Simulation is a globally recognised brand,...
PR Newswire
02/08/2023
Klinikk Hausken Deploys Fairtility's CHLOE Technology, Bringing Transparent AI…
"We selected CHLOE EQ™ for its unmatched ability to provide quantifiable biological data on embryo development in language that our embryologists trust: human biology. Its transparency and interpretability set it apart from other AI-based decision support tools available," said Shabana Sayed, Senior Embryologist, and IVF Lab Manager at Klinikk Hausken, part of Medicover. "CHLOE EQ's reliability and transparency have been instrumental in both our clinical and embryology teams…
PR Newswire
02/08/2023
InDex Pharmaceuticals has been granted a new patent in Europe for the commercial…
"We are pleased that this important patent has been granted by the European Patent Office," said Jenny Sundqvist, CEO of InDex Pharmaceuticals. "It is a key component in our robust patent portfolio for cobitolimod as it specifically protects the intended commercial product and provides broader protection than a method of use patent." "We are pleased that this important patent has been granted by the European Patent Office," saidJenny Sundqvist, CEO of InDex…
PR Newswire
02/08/2023
Ad Hoc Press Release pursuant to Art.53 Swiss Listing Rules
Disclosure Disclosure The information was submitted for publication, through the contact persons set out below, at07:00 CESTon August 2, 2023. Further information is available on investors.firmenich.com. ENDS About Firmenich Firmenich International SA ("Firmenich") announced onMay 9, 2023the completion of its merger with DSM to establish DSM-Firmenich AG, the leading innovation partner in nutrition, health, and beauty. Prior to the merger, Firmenich was the world's...
PR Newswire
02/08/2023
NEW Superdrug summer exclusive: foodspring releases new protein+ range with…
The foodspring x Davina product range is designed to inspire people to lead a healthy lifestyle. The shakes are different from traditional protein powders and reflect Davina's positive and holistic approach to health, fitness and nutrition. The range has been carefully formulated to support general wellbeing, and fit around busy lifestyles by helping balance energy levels throughout the day, or to wind down, relax and recover in the evening. The shakes are not only high in protein but also…
PR Newswire
02/08/2023
dsm-firmenich reports H1 2023 results
H1 2023 highlights H1 2023 highlights Geraldine MatchettandDimitri de Vreeze, Co-CEOs, commented:"We are well advanced in the integration phase of the merger and excited by the positive response of customers to our enhanced business proposition, giving us even greater confidence in the delivery of our synergy targets. The performance of our Perfumery & Beauty and Taste, Texture & Health units in the first six months demonstrates the quality of these businesses and the...
PR Newswire
02/08/2023
Mucopolysaccharidosis Market to Accelerate Substantially, Predicts DelveInsight…
Key Takeaways from the Mucopolysaccharidosis Market Report Key Takeaways from the Mucopolysaccharidosis Market Report Discover which therapies are expected to grab the major mucopolysaccharidosis market share @Mucopolysaccharidosis Market Report Mucopolysaccharidosis Overview Mucopolysaccharidosis (MPS) refers to a group of inherited metabolic disorders characterized by the accumulation of glycosaminoglycans (GAGs) within cells throughout the body. These complex sugars play...
PR Newswire
01/08/2023
Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext Growth ISIN code: FR0010425595DateTotal number of shares in the capitalTotal number of voting rights 07/31/202355,583,76861,509,936 About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T...
Nasdaq GlobeNewswire
01/08/2023
Theriva Biologics to Host Conference Call and Webcast to Discuss Second Quarter…
ROCKVILLE, Md., Aug.01, 2023(GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it plans to host a conference call on Tuesday, August 8, 2023, at 8:30 a.m. ET to discuss its financial results for the quarter ended June 30, 2023 and provide a corporate update. Individuals may participate in the live call via telephone by...
Nasdaq GlobeNewswire
01/08/2023
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2023
Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1124/07/2023FR001025915055111.04CEUXIPSEN549300M6SGDPB4Z94P1124/07/2023...
Nasdaq GlobeNewswire
01/08/2023
SYGNATURE DISCOVERY ACCELERATES GLOBAL GROWTH WITH MAJOR NORTH AMERICAN…
The transaction creates a significant competitive advantage for Sygnature as it expands its global footprint and business operations to leverage discovery expertise in the North American market. Together, Sygnature Discovery and NuChem are creating a global force that delivers drug discovery expertise to support customer programmes from target validation through to candidate selection, combining the best of North American and UK operations. Marc Lebel, Pharm. D., President and...
PR Newswire
01/08/2023
Monthly Publication of the Number of Shares Composing the Share Capital and of…
Nicox SA Société anonyme with a registered capital of € 50,170,498 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On August 1, 2023, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlementgénéral of the l'AMF) As of July 31, 2023 Total number of shares...
Nasdaq GlobeNewswire
01/08/2023
Investing in the Booming Single Use Consumables Market: Global Market Report…
Market Growth and Outlook Market Growth and Outlook Thesingle use consumables markethas demonstrated robust growth in recent years, and this trend is projected to continue at an impressive rate. According to the Global Market Report for 2023, the market size is expected to reach $3.12 billionin 2023, with a compound annual growth rate(CAGR) of 18.09%.Looking ahead, the market is forecasted to expand further and reach $5.98 billionby 2027, growing at aCAGR of 17.68%...
PR Newswire
01/08/2023
The opportunity within the DNA Encoded Library Market is projected to grow at an…
The DNA encoded library market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors. This can be attributed to the various benefits offered by these platforms, such as cost effectiveness, high diversity, minimal false positives, stability and rapid hit identification. The DNA encoded library market is currently abuzz with activity; industry players have forged several strategic alliances and...
PR Newswire
01/08/2023
Altri Comunicati